CNR Institutional Research Information System

ZUCCA, FABIO ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.229
NA - Nord America 1.708
SA - Sud America 472
EU - Europa 451
Continente sconosciuto - Info sul continente non disponibili 95
AF - Africa 40
OC - Oceania 3
Totale 4.998
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.619
SG - Singapore 908
CN - Cina 529
BR - Brasile 366
VN - Vietnam 278
HK - Hong Kong 205
FR - Francia 143
IT - Italia 99
KR - Corea 85
IN - India 56
CA - Canada 45
DE - Germania 43
BD - Bangladesh 32
GB - Regno Unito 32
JP - Giappone 32
AR - Argentina 30
FI - Finlandia 26
CO - Colombia 22
ID - Indonesia 21
EC - Ecuador 20
MX - Messico 19
NL - Olanda 16
VE - Venezuela 14
ES - Italia 13
ZA - Sudafrica 13
RU - Federazione Russa 11
IL - Israele 10
LU - Lussemburgo 10
MY - Malesia 9
IQ - Iraq 8
MA - Marocco 7
PY - Paraguay 7
UA - Ucraina 7
AE - Emirati Arabi Uniti 6
PE - Perù 6
SA - Arabia Saudita 6
TR - Turchia 6
AZ - Azerbaigian 5
IE - Irlanda 5
KE - Kenya 5
PL - Polonia 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
CR - Costa Rica 4
JO - Giordania 4
NP - Nepal 4
PA - Panama 4
RS - Serbia 4
SE - Svezia 4
TT - Trinidad e Tobago 4
CL - Cile 3
CZ - Repubblica Ceca 3
LB - Libano 3
NI - Nicaragua 3
PH - Filippine 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
AT - Austria 2
BE - Belgio 2
BS - Bahamas 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PS - Palestinian Territory 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
YT - Mayotte 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CV - Capo Verde 1
DJ - Gibuti 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
KG - Kirghizistan 1
LV - Lettonia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SC - Seychelles 1
TG - Togo 1
Totale 4.902
Salva come PNG Salva come JPEG
Città #
Singapore 524
Santa Clara 412
Hefei 220
San Jose 200
Hong Kong 198
Ashburn 110
Ho Chi Minh City 104
Beijing 100
Lauterbourg 91
Seoul 84
Hanoi 60
Los Angeles 36
Dallas 30
São Paulo 28
Frankfurt am Main 22
New York 20
Tokyo 19
Guangzhou 18
Helsinki 17
Atlanta 15
Milan 15
Brescia 13
Houston 13
Brooklyn 12
Buffalo 12
Mumbai 12
Rio de Janeiro 12
Brasília 11
Biên Hòa 10
Da Nang 10
Luxembourg 10
Orem 10
Portsmouth 10
Bengaluru 9
Guayaquil 9
Johannesburg 9
Minamishinagawa 9
Boston 8
Chicago 8
Belo Horizonte 7
Philadelphia 7
Quận Bình Thạnh 7
Rome 7
Turku 7
Bogotá 6
Curitiba 6
Düsseldorf 6
Guarulhos 6
Haiphong 6
Madrid 6
Memphis 6
Phoenix 6
Queens 6
Salvador 6
San Antonio 6
Toronto 6
Arese 5
Baku 5
Charlotte 5
Dhaka 5
Duque de Caxias 5
Las Vegas 5
Manaus 5
Milwaukee 5
Montreal 5
Nuremberg 5
Porto Alegre 5
Ribeirão Preto 5
St Louis 5
The Bronx 5
Amman 4
Asunción 4
Birmingham 4
Buenos Aires 4
Campinas 4
Can Tho 4
Chennai 4
Cincinnati 4
Columbus 4
Council Bluffs 4
Denver 4
Dublin 4
Goiânia 4
Hamilton 4
Hyderabad 4
Jacksonville 4
Kolkata 4
Kuala Lumpur 4
Lima 4
Medellín 4
Miami 4
Nairobi 4
New London 4
Phillipsburg 4
Sacramento 4
San Francisco 4
Springfield 4
Warsaw 4
Amsterdam 3
Bandung 3
Totale 2.805
Salva come PNG Salva come JPEG
Nome #
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. 228
Engineered nanoparticles. How brain friendly is this new guest? 106
New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals 98
Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease 90
Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. 89
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease 88
Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson's Disease 83
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders 76
Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells 75
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease 75
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role 72
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease 71
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain 68
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease 67
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. 66
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models 65
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects 65
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells 63
The role of neuromelanins in the oxidative stress of Parkinson's disease. 62
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease 62
Neuromelanin of the Human Substantia Nigra: An Update 62
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases 58
Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson's Disease 57
Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease 57
Water-Soluble Melanin-Protein-Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus 57
Convenient Synthetic Method Of Putative Degradative Markers To Identify Various Catecholic Metabolites In Addition To Dopamine And Norepinephrine Incorporated In Neuromelanin. 56
Neuromelanin a chelator of iron and other metals in catecholaminergic neurons of substantia nigra and locus coeruleus. 54
Melanic Pigments in the Human brain 53
Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A 52
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease 52
Synthetic models of neuromelanin with fibrillated protein in the core 51
A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease 51
Neuromelanins Isolated from Different Regions of the Human Brain Exhibit a Common Surface Photoionization Threshold 50
Contrast mechanisms associated with neuromelanin-MRI 50
The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface. 49
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology 49
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest 49
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. 49
Protective and toxic roles of dopamine in Parkinson's disease 49
Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids. 48
Neuromelanin organelle pathways in aging and neurodegeneration of Parkinson's Disease 48
IRON, COPPER AND THEIR MOLECULES IN SUBSTANTIA NIGRA OF NORMAL SUBJECTS DURING AGING 47
The role of neuromelanin organelle pathways in parkinson's disease 46
NEUROMELANINS ACCUMULATE IN NEURONS DURING HUMAN BRAIN AGING AND BIND METALS 46
The Role of Iron in Neurodegeneration 46
Proteomic profile of neuromelanin and neuromelanin-containing organelles 46
The Neuromelanin of Human Substantia Nigra: Physiological and Pathogenic Aspects 45
Neuromelanin activates microglia and induces substantia nigra neuron death. A key mechanism of Parkinson's disease. 45
Neuromelanin organelles pathways in brain aging and Parkinson's disease 44
The structure of neuromelanin as studied by chemical degradative methods 44
NEUROMELANIN ORGANELLES AND AUTOPHAGY IN BRAIN AGING 44
NEUROMELANIN ORGANELLES PATHWAYS AND NEURODEGENERATION IN PARKINSON'S DISEASE 43
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 43
Protective and neurotoxic role of neuromelanin in human brain 43
Modeling Midbrain and Brainstem Neuromelanins to Characterize Metal Binding and Associated MRI Contrast in Parkinson's and Alzheimer's Diseases 43
α-Synuclein and Dopamine Metabolites DOPAL and DOPAC: A Pathway to New Synthetic Neuromelanin Models 42
Neuromelanins in brain aging and Parkinson's disease. 42
Protective and toxic role of neuromelanin in brain aging and Parkinson's disease 40
Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry 39
Melanin-protein fibrils conjugates as models to study neuromelanin structure and reactivity. 39
Application of Pump-Probe Imaging Towards Chemical and Structural Characterization of Neuromelanin. 38
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 38
Neuromelanin and metals in brain aging and neurodegeneration. 36
Biosynthetic pathway to neuromelanin and its aging process 35
Neuromelanin-sensitive MRI as a proxy-measure of dopamine function in neuropsychiatric illness. 35
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes. 34
Neuromelanin and metals in brain aging and neurodegeneration. 34
The application of the Neutron Activation Analysis for trace metals determination in human brain tissues and substantia nigra neuromelanin. 33
Melanins and melanogenesis: from pigment cells to human health and technological applications 33
Neuromelanins, oxidative stress and Parkinson's disease 32
Iron, copper and their proteins in substantia nigra of human brain during aging. 32
Neuromelanin in human brain: protective and toxic role. 31
The role of neuromelanin and iron in brain aging and Parkinson's disease. 31
Effect of prolonged exposure to 50 Hz electric and magnetic fields on neurotransmitters in rat brain 30
The role of neuromelanin in brain aging and neurodegeneration of Parkinson's disease 30
Effect on neurotransmitters and receptors in rat exposed to 50Hz electric and magnetic fields from conception to adult life 30
Iron and copper molecules in aging of human substantia nigra. Consequences for neurodegenerative processes. 29
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 29
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration 29
Neuromelanin in the human brain: protective and toxic role. 29
Neuromelanin activates microglia and induces substantia nigra neuron death. 29
Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus 28
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes 28
The role of neuromelanin in brain aging and Parkinson's disease. 28
NEURONAL MHC-I DISPLAY IN T-CELL MEDIATED NEURODEGENERATION 28
The structure, synthesis and role of neuromelanins in brain aging and neurodegeneration 28
A modern imaging investigation of neuromelanin extracted from the substantia nigra region of the human brain. 27
Chemistry and biophysics of melanins 27
Activation of microglia by neuromelanin: correlation of neuromelanin phagocytosis and degradation, reactive oxygen species production, and ventral midbrain neuron death. 27
Identification and quantification of dolichol and dolichoic acid in neuromelanin from substantia nigra of the human brain 27
Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference. 26
EXPRESSION OF MHC-I ON SUSBTANTIA NIGRA AND LOCUS COERULEUS OF HUMAN CONTROL and PARKINSON'S DISEASE SUBJECTS: IMPLICATIONS IN DOPAMINERGIC NEURONAL DEGENERATION 25
The role of neuromelanin in brain aging and Parkinson's disease. 25
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 25
Effetti dell'esposizione cronica a CEM di 50 Hz su neurotrasmettitori e recettori nel cervello di ratto 25
The role of iron in brain ageing and neurodegenerative disorders 24
The neurodegenerative role of neuromelanin in Parkinson's disease 24
Iron, copper and zinc concentration in substantia nigra of human brain during aging. 24
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 24
Is neuromelanin of substantia nigra protective or toxic for neurons? 23
Totale 4.767
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.256
article - articoli 9.508
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 336
Totale 27.100
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202444 0 0 0 0 0 0 0 0 2 0 41 1
2024/20251.618 2 8 136 49 379 46 22 132 49 60 376 359
2025/20262.603 131 348 219 379 467 122 345 151 111 146 86 98
2026/2027733 195 281 257 0 0 0 0 0 0 0 0 0
Totale 4.998